Funded Tech Companies

NeurAxon

NeurAxon is a biopharmaceutical venture, based in Mississauga ON. Financial backing was provided by Knight Therapeutics, private investors and BDC Venture Capital.

Company Overview

Company Name
NeurAxon
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
16-1375 Southdown Rd. 318
Mississauga ON, L5J 2Z1
Canada
Email Address

Company Background Information

Overview
NeurAxon is a leader in discovering and developing next generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.
Profile
NeurAxon LinkedIn Company Profile
Social Media
NeurAxon Company Twitter Account
Company News
NeurAxon News
Facebook
NeurAxon on Facebook
YouTube
NeurAxon on YouTube
Last Transaction
1/2/2015

Financing History

Date
Type
Amount
Venture Equity
$1,750,000
Debt
$782,171
Debt
$8,750,000
Venture Equity
$32,000,000


Management Team

Title
Name
Email & Social
President
John Andrews
  John Andrews LinkedIn Profile  John Andrews Twitter Account  John Andrews News  John Andrews on Facebook
VP - Regulatory Affairs
Tom Lategan
  Tom Lategan LinkedIn Profile  Tom Lategan Twitter Account  Tom Lategan News  Tom Lategan on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Neurava | NeuReality

 

Share this article

 


About Our VC & M&A Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary